A study surveyed 300 breast cancer patients taking the drug Capvex. 250 of the patients were healed after 10 weeks. The parameter is the proportion of all patients taking Capvex who are healed within 10 weeks. The statistic is the proportion of 250 out of the 300 patients in the sample who were healed after 10 weeks.